personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

Main Sessions

Thursday 26 September | 11.00 - 13.00
Main Session 1 - Ocular Tumours

Chairpersons: D. Wong UK, H. Heiman GERMANY

S. Coupland UK
Update on intraocular lymphoma

L. Zografos SWITZERLAND
Imaging of Ocular Tumours

M. Zeschnigk GERMANY
The genetics of uveal melanoma

L. Desjardins FRANCE
Retinoblastoma management update

N. Bornfeld GERMANY
Radiotherapy of uveal melanoma

N. Bechrakis AUSTRIA
Surgical management of uveal melanoma

H. Heimann GERMANY
Vascular tumours


Thursday 26 September | 14.00 - 16.00
Main Session 2 - Neovascular AMD

Chairpersons: U. Schmidt-Erfurth AUSTRIA

N. Ferrara USA
Therapeutic use of VEGF-inhibition

R. Spaide USA
A clinical understanding of anti-VEGF therapy in AMD

U. Schmidt-Erfurth AUSTRIA
The Euretina guidance for the management of neovascular AMD

S. Waldstein AUSTRIA
Predictors for visual outcome in the treatment of neovascular AMD

P.  D'Amore USA
The Role of VEGF in the Adult

R.  Schlingemann THE NETHERLANDS
BRAMD: Ranibizumab versus bevacizumab in the Netherlands

U. Chakravarthy UK
Two year outcomes in the IVAN trial

Friday 27 September | 08:00 – 10:00
Main Session 3 - Ocular Inflammation

Chairpersons: P. Lehoang FRANCE, C. Pavesio UK

P. LeHoang FRANCE
Introduction

P. LeHoang FRANCE
Stepladder approach for the treatment of non infectious uveitis

C. Deuter GERMANY
Biologics: IFN in the Treatment of Non infectious Uveitis

D. Kilmartin IRELAND
Biologics: antibodies and new therapies in the pipeline

C. Pavesio UK
Local Therapy

E. Miserocchi ITALY
Update on the Treatment of Non Infectious Pediatric Uveitis

A. Adan SPAIN
Wide-field retinal imaging in the management of posterior uveitis

General Discussion

C. Pavesio UK
Conclusion

Friday 27 September | 14:00 – 16:00
Main Session 4 - Dry AMD

Chairpersons: S. Wolf Switzerland, M. la Cour DENMARK

C. Klaver THE NETHERLANDS
Genotype and AMD phenotype - is there a correlation?

J. Monés SPAIN
Characterization of retinal layers in foveal sparing secondary to gepgraphic atrophy

S. Vas Sadda USA
Results of the AREDS 2 Study

M. Rudolph GERMANY
Causal AMD Therapy by targeting Lipid-rich Deposits in Bruch's Membran and in the sub-RPE Space?

L. Da Cruz UK
Cell transplantation approaches for macular degeneration

G. Querques FRANCE
Advances on imaging of dry age-related macular degeneration

F. Holz GERMANY
The MAHALO Phase II Study: Safety, Tolerability and Evidence of Activity of Lampalizumab (Anti-factor D) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Friday 27 September | 16.00 - 18.00
Main Session 5 - EURETINA Innovation Award

Chairperson: E. Stefansson ICELAND

Saturday 28 September | 08.00 - 10.00
Main Session 6 - Imaging

Chairpersons: F. Holz GERMANY, G. Soubrane FRANCE

S. Wolf SWITZERLAND
Autofluorescent lifetime measurements of the retina

W. Harmening USA
Multi-wavelength adaptive optics SLO imaging and micro stimulation

G. Staurenghi ITALY
Widefield imaging in retinal diseases

C. Egan UK
Imaging strategies in MacTel 2

S. Schmitz-Valckenberg GERMANY
Monitoring anti-VEGF therapy with SD-OCT - the ORCA Project

C. Boon THE NETHERLANDS
SD-OCT and fundus autofluorescence imaging for differential diagnosis of macular and retinal dystrophies


Saturday 28 September | 11.00 - 13.00
Main Session 7 - Innovative Vitreoretinal Surgery

Chairpersons: G. Richard GERMANY, D. Pelayes ARGENTINA

B. Corcostegui SPAIN
PVR: Pharmacological or surgical approach?

D. Wong HONG KONG
Endotamponades: An update

B. Stemplewitz GERMANY
Dyes in vitreoretinal surgery: An update

Z. Koshy UK
Management of AMD with submacular hemorrhage: Unsolved problems and open questions

G. McGowan UK
AMD with submacular hemorrhage: New insights from a population-based study and an international survey of current treatment practice

J. Hillenkamp GERMANY
Subretinal co-application rtPA+anti-VEGF for AMF with submacular hemorrhage: Outcomes and compatibility

D. Steel UK
AMD with “massive” subretinal hemorrhage: Hopeless or not?

P. Stalmans BELGIUM
Effect of oil viscosity on emulsification

Saturday 28 September | 14.00 - 16.00
Main Session 8 - Retinal Vein Occlusions

Chairpersons: A. Loewenstein ISRAEL, F. Bandello ITALY

F. Bandello ITALY
Anti-VEGF

C. Pournaras SWITZERLAND
Pathophysiology

B. Kuppermann USA
Steroids

F. Boscia ITALY
Vitreoretinal interface in RVO and role of surgery

M. Goldstein ISRAEL
Case presentations

I. Mc Allister AUSTRALIA
Laser bypass or anastomosis for CRVO

Sunday 29 September | 08.00 - 10.00
Main Session 9 - PVR & Retinal Detachment

Chairpersons: B. Aylward UK, J.C. Pastor SPAIN

C. Meyer SWITZERLAND
Improving management of PVR with vital dyes

L. Visser SOUTH AFRICA
Retinal detachment from progressive outer retinal necrosis

D. Yorsten UK
Outcomes of retinal detachment surgery

S. Lesnik Oberstein THE NETHERLANDS
Primary retinectomy in proliferative vitreoretinopathy

J. Hillenkamp GERMANY
Retinal detachment in open globe injuries

J. Carlos Pastor SPAIN
Current and future pharmacological treatment for PVR

D. Charteris UK
Update on the pathophysiology of PVR'

K. Drenser USA
Retinal detachment surgery in children

Sunday 29 September | 11.00 - 13.00
Main Session 10 - Diabetic Retinopathy

Chairpersons: E. Stefansson ICELAND, F. Bandello ITALY

T. Gardner USA
Pathophysiology of diabetic retinopathy.

E. Stefánsson ICELAND
Epidemiology of diabetic retinopathy and prevention of blindness.

F. Bandello ITALY
Diabetic macular edema. New developments in diagnostics and treatment.

U. Schmidt-Erfurth AUSTRIA
Proliferative diabetic retinopathy

D. Beebe USA
Hypoxia in diabetic retinopathy

Discussion

EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy